0002060755-26-000018.txt : 20260319 0002060755-26-000018.hdr.sgml : 20260319 20260319152105 ACCESSION NUMBER: 0002060755-26-000018 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260319 DATE AS OF CHANGE: 20260319 EFFECTIVENESS DATE: 20260319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vesalius Longevity Labs (SPV) Inc. CENTRAL INDEX KEY: 0002056924 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-577064 FILM NUMBER: 26773968 BUSINESS ADDRESS: STREET 1: 1500 - 1055 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 4N7 BUSINESS PHONE: 507-6666-6151 MAIL ADDRESS: STREET 1: 1500 - 1055 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 4N7 D 1 primary_doc.xml X0708 D LIVE 0002056924 Vesalius Longevity Labs (SPV) Inc. 1500 - 1055 WEST GEORGIA STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 4N7 5076666151 BRITISH COLUMBIA, CANADA None None Corporation true 2024 Shannon Anderson 1500 - 1055 West Georgia Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4N7 Director Promoter Christina Phalen 1500 - 1055 West Georgia Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4N7 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-03-11 false true true true false 0 6712500 6712500 0 Total Offering Amount equals the price of an aggregate of 4,625,000 shares and 8,800,000 Subscription Receipts at $0.50 per share. Each Subscription Receipt entitles the holder to acquire shares for no additional consideration subject to certain events. false 19 0 0 0 false Vesalius Longevity Labs (SPV) Inc. /s/ Shannon Anderson Shannon Anderson Director 2026-03-19